Peter J. Rossi, MD, FACS, led a panel discussion on “Updates in Brachytherapy” virtually during the 21st Annual Future Directions in Urology Symposium in August 2020.
How to cite: Rossi, Peter J. “Panel Discussion: Next Generation Genomics and Prostate Cancer Biomarkers” August 10th, 2020. Accessed Nov 2024. https://grandroundsinurology.com/updates-in-brachytherapy-2020/
Summary:
Peter J. Rossi, MD, a radiation oncologist affiliated with Kaiser Permanente and Valley View Hospital in Glenwood Springs, Colorado, discusses the benefits of brachytherapy for patients with intermediate-risk prostate cancer, arguing that it should be in wider use in the United States than it currently is. He notes that there is a lot of level I evidence for brachytherapy’s effectiveness, and that low dose rate brachytherapy plus external beam radiation therapy (EBRT) plus androgen deprivation therapy (ADT) is far more effective after several years than EBRT plus ADT alone, as is EBRT plus a high dose rate brachytherapy boost. This difference has largely been ignored in the US because of a slightly higher toxicity rate with brachytherapy, but Dr. Rossi argues that the treatment has improved over time, especially with the introduction of MRI-based brachytherapy. Dr. Rossi concludes by noting that there needs to be better messaging around brachytherapy, as well as greater efforts to train new brachytherapists.
About The 2020 Virtual Future Directions in Urology Symposium
The Future Directions in Urology Symposium was founded 21 years ago to reflect on the current state of the urology community and predict trends in the treatment of urology conditions in the following 5-10 years. This conference brings together experts in the field, including urologists, medical oncologists, radiation oncologists, family practice doctors, researchers, and industry leaders to review current trends and prospects. Dr. Rossi presented this lecture during this year’s virtual conference in August 2020.
ABOUT THE AUTHOR
Peter J. Rossi, MD, a certified radiation oncologist, is associated with the Calaway - Young Cancer Center at Valley View Hospital in Glenwood Springs, Colorado. Holding a medical degree from Wayne State University School of Medicine, he completed his internship and residency at the Naval Medical Center in San Diego, California, and Wake Forest University in Winston-Salem, North Carolina. Dr. Rossi was formerly an associate professor at Emory University School of Medicine and the medical director of oncology at Winship Cancer Institute at Emory Saint Joseph’s Hospital in Atlanta, Georgia. He brings over 25 years of clinical experience to his practice. His numerous publications highlight his commitment to improving quality of life outcomes and showcase innovative approaches in brachytherapy, radiation therapy, and multidisciplinary care for prostate cancer. Actively contributing to a multidisciplinary team, Dr. Rossi is devoted to delivering exceptional care to cancer patients.
